Champions Oncology Inc
NASDAQ:CSBR

Watchlist Manager
Champions Oncology Inc Logo
Champions Oncology Inc
NASDAQ:CSBR
Watchlist
Price: 7.505 USD -0.6% Market Closed
Market Cap: 102m USD
Have any thoughts about
Champions Oncology Inc?
Write Note

Net Margin
Champions Oncology Inc

-1.1%
Current
-7%
Average
0.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1.1%
=
Net Income
-598k
/
Revenue
53.6m

Net Margin Across Competitors

Country US
Market Cap 102.8m USD
Net Margin
-1%
Country US
Market Cap 1.2T USD
Net Margin
9%
Country US
Market Cap 200.4B USD
Net Margin
14%
Country US
Market Cap 165.1B USD
Net Margin
18%
Country KR
Market Cap 67.9T KRW
Net Margin
24%
Country CH
Market Cap 38.3B CHF
Net Margin
9%
Country US
Market Cap 38.7B USD
Net Margin
22%
Country US
Market Cap 35.8B USD
Net Margin
9%
Country US
Market Cap 26.7B USD
Net Margin
21%
Country US
Market Cap 24B USD
Net Margin
17%
Country CN
Market Cap 163.2B CNY
Net Margin
21%
No Stocks Found

Champions Oncology Inc
Glance View

Market Cap
102.8m USD
Industry
Life Sciences Tools & Services

Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The company is headquartered in Baltimore, Maryland and currently employs 194 full-time employees. This technology includes the Company’s in-vivo, ex-vivo and biomarker platforms, oncology software solutions, and computational-based discovery platforms. The Company’s TumorGraft Technology Platform (The Platform) provides select services to pharmaceutical and biotechnology. The Company’s software as a service business is centered around its software platform and data tool, Lumin Bioinformatics (Lumin), which contains comprehensive information derived from its research services and clinical studies. The Company’s drug discovery and development business leverages the computational and experimental capabilities within its platforms. Their discovery strategy utilizes its datacenter, coupled with artificial intelligence and other advanced computational analytics, to identify novel therapeutic targets.

CSBR Intrinsic Value
7.1 USD
Overvaluation 5%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1.1%
=
Net Income
-598k
/
Revenue
53.6m
What is the Net Margin of Champions Oncology Inc?

Based on Champions Oncology Inc's most recent financial statements, the company has Net Margin of -1.1%.